ABSI (STOCKS)
Absci Corporation Common Stock
$9.459800
-0.040200 (-0.42%)
Prev close: $9.500000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sean McClain
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,944.89M
- Employees
- 157
- P/E (TTM)
- -11.82
- P/B (TTM)
- 6.62
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.56M |
| Benefits Costs and Expenses | $122.64M |
| Costs And Expenses | $122.64M |
| Nonoperating Income/Loss | $5.12M |
| Operating Expenses | $127.76M |
| Selling, General, and Administrative Expenses | $35.28M |
| Research and Development | $86.49M |
| Other Operating Expenses | $5.99M |
| Operating Income/Loss | -$126.20M |
| Income/Loss From Continuing Operations After Tax | -$121.08M |
| Income/Loss From Continuing Operations Before Tax | -$121.08M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$121.08M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$121.08M |
| Net Income/Loss Available To Common Stockholders, Basic | -$121.08M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.79 |
| Diluted Earnings Per Share | -$0.79 |
| Basic Average Shares | 303,649,172 |
| Diluted Average Shares | 303,649,172 |
| Assets | $268.92M |
| Current Assets | $208.27M |
| Noncurrent Assets | $60.65M |
| Intangible Assets | $40.05M |
| Other Non-current Assets | $20.60M |
| Liabilities | $22.79M |
| Current Liabilities | $19.60M |
| Accounts Payable | $7.16M |
| Wages | $3.47M |
| Other Current Liabilities | $8.97M |
| Noncurrent Liabilities | $3.19M |
| Equity | $246.13M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $246.13M |
| Liabilities And Equity | $268.92M |
| Net Cash Flow From Operating Activities | -$108.08M |
| Net Cash Flow From Operating Activities, Continuing | -$108.08M |
| Net Cash Flow From Investing Activities | -$12.73M |
| Net Cash Flow From Investing Activities, Continuing | -$12.73M |
| Net Cash Flow From Financing Activities | $174.44M |
| Net Cash Flow From Financing Activities, Continuing | $174.44M |
| Net Cash Flow | $53.63M |
| Net Cash Flow, Continuing | $53.63M |
| Comprehensive Income/Loss | -$121.24M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$121.24M |
| Other Comprehensive Income/Loss | -$121.24M |